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OBJECTIVES We sought to test the hypothesis that the pulse transmission coefficient (PTC) can serve as
a nonhyperemic physiologic marker for the severity of coronary artery stenosis in humans.
BACKGROUND Coronary lesions may impair the transmission of pressure waves across a stenosis, potentially
acting as a low-pass filter. The PTC is a novel nonhyperemic parameter that calculates the
transmission of high-frequency components of the pressure signal through a stenosis. Thus,
it may reflect the severity of the coronary artery stenosis. This study was designed to examine
the correlation between PTC and fractional flow reserve (FFR) in patients with coronary
artery disease.
METHODS Pressure signals were obtained by pressure guidewire in 56 lesions (49 patients) in the
nonhyperemic state and were analyzed with a new algorithm that identifies the high-
frequency components in the pressure signal. The PTC was calculated as the ratio between
the distal and proximal high-frequency components of the pressure waveform across the
lesion. The FFR measurements were assessed with intracoronary adenosine.
RESULTS There was a significant correlation between PTC and FFR (r  0.81, p  0.001). By using
a receiver operating characteristic analysis, we identified a PTC  0.60 (sensitivity 100%,
specificity 98%) to be the optimal cutoff value for predicting an FFR  0.75.
CONCLUSIONS Pulse transmission coefficient is a novel nonhyperemic parameter for the physiologic
assessment of coronary artery stenoses. It correlates significantly with FFR and may predict
an FFR 0.75 with high accuracy. Pulse transmission coefficient may be useful as an adjunct
measurement to FFR, especially in patients with microcirculatory disease and impaired
maximal hyperemia. (J Am Coll Cardiol 2002;39:1012–9) © 2002 by the American College
of Cardiology Foundation
Coronary angiography is currently the gold standard for
assessing coronary artery disease (CAD). In many patients
with CAD clinical decision-making requires an evaluation
of the functional severity of the coronary lesion (1–3). The
recent introduction of pressure sensor-tipped guidewires has
enabled physiologic assessment of lesion severity during
coronary catheterization by calculation of myocardial frac-
tional flow reserve (FFR), which correlates with the degree
of myocardial ischemia and coronary events (4–9). Thus, an
intracoronary physiologic approach complements the ana-
tomic assessment of the lesion, obtained by coronary an-
giography and, therefore, facilitates decision-making re-
garding the need for intervention.
Spectral analysis of the arterial pressure waveform has
identified the dicrotic notch as a marker for high-frequency
content of the pressure signal (10). Previous studies dem-
onstrated that analysis of the pressure waveform may be
associated with the degree of atherosclerotic vascular disease
(11,12). More recent studies have demonstrated that aortic
stenosis reduces pulse transmission, as reflected in abnor-
malities of carotid pulse waveform (13,14). These studies
suggest that the attenuation of the high-frequency compo-
nents of the pulse waveform may indicate the existence of
significant flow obstruction across the lesion site. Therefore,
we have assessed a novel parameter, the pulse transmission
coefficient (PTC), which calculates the transmission of
high-frequency components of the intracoronary pressure
signal through a stenosis in the nonhyperemic state.
This current study was designed to test the hypothesis
that PTC can serve as a nonhyperemic physiologic marker
for the severity of coronary artery stenosis in humans, in
vivo.
METHODS
Patient population. The study population consisted of 49
consecutive patients (56 lesions) who were referred for
coronary angiography and were found to have intermediate
coronary lesions defined as 40% to 70% diameter stenosis by
angiographic assessment. Exclusion criteria included: unsta-
ble angina, heart failure (ejection fraction 40%), signifi-
cant left main disease (left main stenosis 50% or ostial left
main disease 30%), multiple lesions in the same vessel,
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recent myocardial infarction (5 days) and significant
valvular disease. The study protocol was approved by the
Institutional Review Board, and a consent form was ob-
tained from all patients.
Study protocol. Diagnostic coronary angiography was per-
formed using 6F to 7F coronary catheters with the standard
femoral approach after routine procedures. To avoid spasm
and to achieve maximal epicardial vasodilation, sublingual
(0.4 mg) or intracoronary nitroglycerin (0.1 mg to 0.3 mg)
was routinely administered before initial and final angio-
grams and before advancement of the pressure wire across
the lesion. During the procedure, heart rate was monitored
and aortic pressure was recorded by the guiding catheter.
Off-line quantitative coronary angiography (QCA) analysis
was performed at the Mayo Clinic Core Laboratory by an
investigator blinded to the results of the physiologic assess-
ment using an automated contour detection algorithm
(QCA-CMS version 5.0 MEDIS, Leiden, the Netherlands).
Pressure measurement and calculation of FFR. After the
diagnostic coronary angiogram, the diagnostic coronary cath-
eters were replaced by guiding catheters that were advanced
through the femoral sheath to engage into the ostium of
the coronary artery. Intracoronary pressure was measured with
a high-fidelity pressure guidewire (0.014 in., PressureWire,
Radi Medical, Uppsala, Sweden or WaveWire, EndoSonics,
Rancho Cordova, California) that was first set at zero and
calibrated outside the body. Aortic pressure was measured
with the tip of the guiding catheter, which transmits the
pressure wave to a fluid-filled pressure monitoring system.
After advancing the pressure sensor (3 cm proximal to the
guidewire tip) to the guiding catheter tip, the pressure signal
acquired by the guidewire was compared with the fluid-
filled aortic pressure and adjusted if necessary. Both the
pressure wire signal and the fluid-filled aortic pressure were
simultaneously fed into the SmartFlow (Florence Medical
Ltd., Kfar Saba, Israel) console for the calculation of the
FFR and further signal processing. The wire was initially
advanced across the lesion, and the pressure-sensor was
located immediately proximal to the lesion. Baseline pres-
sures were recorded proximal to the lesion. Next, the wire
was further advanced placing the pressure sensor distal to
the lesion. Distal pressure was acquired both at baseline and
during maximal hyperemia induced with incremental dos-
ages of intracoronary adenosine (starting with 18 g for the
right and 24 g for the left coronary artery). To avoid a
damped aortic pressure tracing due to a catheter filled with
contrast or blood, all fluid-filled pressure measurements
were recorded after a saline flush of the catheters. The FFR
value was obtained in the usual fashion by calculating the
ratio of the mean distal pressure to the mean proximal
pressure during maximal hyperemia.
Pressure signal processing and calculation of PTC. The
resting, or nonhyperemic, high-fidelity pressure signals
obtained by the pressure guidewire were analyzed by a new
algorithm (Florence Medical Ltd.) that identifies the high-
frequency component in the pressure waveform. The PTC
value was calculated online by the SmartFlow device algo-
rithm as the ratio between the distal and proximal high-
frequency components of the pressure signal in the nonhy-
peremic state (Appendix and Fig. 1). It has been previously
demonstrated that FFR is less subjective to hemodynamic
changes (15). Nevertheless, to avoid the possible effect of
pressure dumping on the accuracy of PTC and FFR
calculations, due to pre-administration of nitroglycerin,
pressure recording was performed when a pressure restora-
tion was obtained. The PTC value for each lesion was
calculated as the mean of 10 consecutive pressure wave-
forms. Because the high-frequency components at the
dicrotic notch segment, from which the PTC is derived, are
at a much higher range than the respiratory or the heart rate
frequencies (6 Hz vs. 0.2 to 0.4 Hz or 1 Hz, respec-
tively), the PTC value is not affected by either respiratory or
heart rate changes.
Statistical analysis. All numerical data are presented as
mean SD. For the physiologic lesion analysis, the mini-
mum obtained FFR value (maximum hyperemia) and its
corresponding PTC were used. Simple linear regression
analysis was used to calculate Pearson’s correlation coeffi-
cients between FFR and PTC indexes of lesion severity,
with their level of significance. The best fitted cutoff PTC
value for predicting FFR 0.75 was determined by a
receiver operating characteristic (ROC) curve analysis. The
chi-square test for association was used to calculate the
association between noninvasive functional test results and
both FFR and PTC categorized values. A value of p  0.05
was considered statistically significant.
RESULTS
The study patients (n  49) were mostly men (74%), with
a mean age of 62 years (range: 43 to 83 years). The
demographic and clinical characteristics of the patients are
outlined in Table 1. The assessed lesions in this present
study were divided into two subgroups by the PTC cutoff
point of 0.6. In the subgroup with PTC0.6, there were 15
patients with 16 lesions, whereas, in the subgroup with
PTC 0.6, there were 34 patients with 40 lesions. There
were no significant differences in age (66 vs. 60 years,
respectively, p  NS) or male gender (60% vs. 79%
respectively, p  NS) between the two subgroups. The
distribution of risk factors as well as the clinical presentation
in the two subgroups was not significantly different. The
angiographic data, the results of the QCA analysis and the
results of the invasive physiologic assessment of lesion
Abbreviations and Acronyms
CAD  coronary artery disease
FFR  fractional flow reserve
PTC  pulse transmission coefficient
QCA  quantitative coronary angiography
ROC  receiver operating characteristic
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severity are outlined in Table 2. The affected vessel was the
left anterior descending coronary artery in 28 (50%) lesions,
the left circumflex coronary artery in 9 (16%) lesions, the
right coronary artery in 16 (29%) lesions and vein graft in 3
(5%) lesions. Thirty-one (63%) patients had single-vessel
disease, 12 (25%) had two-vessel disease and 6 (12%) had
three-vessel disease. Overall, the mean FFR value of the
assessed lesions was 0.80  0.14, whereas the mean PTC
value was 0.71  0.39 (Table 2). Using an ROC curve
analysis, in the overall cohort of 56 lesions, we identified a
PTC value 0.60 (sensitivity 100%, specificity 98%) to be
the best cutoff value for predicting an FFR value 0.75,
with a positive predictive power of 94% and negative
predictive power of 100%. By regression analysis of the
overall cohort of 56 lesions, there was a strong significant
correlation between PTC and FFR (r  0.81, p  0.001,
Fig. 2). The same results were obtained for the whole cohort
of 118 observations. Moreover, all 16 lesions with PTC
0.60 had FFR 0.75, and 39 of 40 lesions with PTC
0.60 had FFR 0.75. Hyperemic frequency analysis of
the pressure waveforms and the calculation of PTC did not
affect the results. Precatheterization noninvasive functional
tests had been performed in only 21 (43%) patients. The
functional testing was positive in 19 patients and negative or
Figure 1. Representative plots for the measured pressure signal and the filtered signal are depicted by solid and dotted lines, respectively. The difference
between the two signals is more prominent at the dicrotic notch segment (A). The region of interest (ROI) (dotted rectangle) for the calculation of pulse
transmission coefficient is defined where the change in pressure signal, which is the difference between the measured and the filtered signal (depicted at
bottom), is maximum (B). BP  blood pressure.
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inconclusive in two patients. Within this subgroup, mean
FFR was 0.76  0.14 while mean PTC was 0.66  0.41,
and there was a strong significant correlation between PTC
and FFR (r  0.78, p  0.001). However, there was no
correlation between either FFR or PTC values, categorized
at cutoff values of 0.75 and 0.60, respectively, and the
functional test results (p 0.29; p 0.24 by chi-square test
for association, respectively). Figure 3 shows representative
coronary angiograms, coronary pressure tracings used to
calculate FFR and pressure waveforms proximal and distal
to the lesion used to calculate PTC, for a typical angio-
graphically intermediate lesion.
DISCUSSION
The present study demonstrates that the nonhyperemic
frequency analysis of the intracoronary pressure waveforms
may serve as a parameter for the assessment of the physio-
logic significance of CAD in humans. Moreover, our results
show that there is a significant correlation between PTC
and FFR and that a categorized cutoff PTC value of 0.60 is
an accurate index for predicting a categorized cutoff FFR
value of significant stenosis.
Thus, our results suggest that PTC can serve as a
nonhyperemic adjunct physiologic index for the functional
assessment of intermediate lesions during coronary cathe-
terization.
Pressure waveform and vascular obstructive disease.
Early observations had suggested that pressure waveform
analysis might be applied to evaluate the severity of athero-
sclerotic vascular disease. Using a classification according to
the appearance of the dicrotic notch in the peripheral
pressure waveform, it was demonstrated that abnormal
pressure waveform with the absence of discrete dicrotic
notch is associated with significant atherosclerotic vascular
disease (11,12). More recently, it was shown that abnormal-
ities in the carotid pulse waveform with alteration or




(49 pts, 56 lesions)
PTC > 0.60
(34 pts, 40 lesions)
PTC < 0.60
(15 pts, 16 lesions)
Mean age (yrs) 62  12 60  12 66  12
Male gender (%) 36 (73%) 27 (79%) 9 (60%)
Risk factors for IHD (no. of patients)
Hypertension (%) 29 (59%) 29 (56%) 10 (67%)
Diabetes mellitus (%) 12 (24%) 8 (24%) 4 (27%)
Hyperlipidemia (%) 27 (55%) 18 (53%) 9 (60%)
Smoker (%) 21 (43%) 15 (44%) 6 (40%)
Previous MI (%) 9 (18%) 7 (21%) 2 (13%)
Previous CABG (%) 7 (14%) 5 (15%) 2 (13%)
Family history (%) 10 (20%) 8 (24%) 2 (13%)
Clinical presentation (no. of patients)
Angina CCS class I (%) 10 (20%) 5 (15%) 5 (33%)
Angina CCS class II–III (%) 39 (80%) 29 (85%) 10 (67%)
CABG  coronary artery bypass grafting; CCS  Canadian Cardiovascular Society; IHD  ischemic heart disease; MI 
myocardial infarction; PTC  pulse transmission coefficient.




(49 pts, 56 lesions)
PTC > 0.60
(34 pts, 40 lesions)
PTC < 0.60
(15 pts, 16 lesions)
Affected vessel (no. of lesions)
LAD (%) 28 (50%) 19 (47%) 9 (56%)
LCX (%) 9 (16%) 6 (15%) 3 (19%)
RCA (%) 16 (29%) 13 (33%) 3 (19%)
Vein graft (%) 3 (5%) 2 (5%) 1 (6%)
Quantitative angiography analysis
Reference diameter (mm) 3.14  0.74 3.06  0.72 3.35  0.79
Minimal luminal diameter (mm) 1.43  0.43 1.54  0.46 1.18  0.22
Lesion length (mm) 11.9  7.44 11.02  7.39 14.09  7.34
Percent diameter stenosis (%) 53  14 49  13 63  13
Percent area stenosis (%) 76  15 72  14 85  11
Physiologic parameters
Mean FFR 0.80  0.14 0.87  0.06 0.63  0.13
Mean PTC 0.71  0.39 0.94  0.08 0.13  0.19
FFR  fractional flow reserve; LAD  left anterior descending coronary artery; LCX  left circumflex artery; PTC  pulse
transmission coefficient; RCA  right coronary artery.
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disappearance of the dicrotic notch is highly correlated with
isolated aortic stenosis (13,14). Furthermore, the absence of
the dicrotic notch in the pulse pressure waveform distal to
aortoiliac disease was associated with significant proximal
artery stenosis, whereas its presence was found as an
excellent index of normal hemodynamics (16). Based on the
aforementioned observations, it seemed that spectral analy-
sis of changes in the pressure waveform may serve as an
indicator for a flow obstruction in arterial conduits.
The high-frequency content of the pressure waveform at
the dicrotic notch and PTC. The dicrotic notch is a
transient upstroke in the pressure waveform reflecting the
deceleration of the arterial pressure after the closure of the
aortic valve. Spectral analysis of the pressure waveform
shows that the dicrotic notch segment contains numerous
high-frequency components representing various reflections
from the periphery (10). Therefore, the dicrotic notch
segment may serve as a region of interest for the analysis of
changes in the high-frequency content of pressure signal.
The recent introduction of the miniature pressure wires
with the acquisition of high-fidelity pressure signal across
intracoronary lesions enables the application of spectral
analysis of the pressure waveform with a reliable detection of
the high-frequency components both proximal and distal to
the lesion. Therefore, we have applied to the coronary lesion
assessment a new algorithm (Florence Medical Ltd.) that
can identify the high-frequency components of the pressure
signal waveform at the dicrotic notch segment and calculates
the PTC as the ratio between the distal and proximal
Figure 2. Linear correlation between pulse transmission coefficient (PTC)
and fractional flow reserve (FFR). The correlation was highly significant
with a high correlation coefficient. Separated by the cutoff values (dotted
lines) of 0.75 and 0.60 for FFR and PTC, respectively, the scattered
distribution of most data points is observed either in the right upper
quadrant or in the left lower quadrant. This represents a good agreement
between the two parameters both above and below the cutoff values.
Figure 3. A representative coronary angiogram and simultaneous tracing of
aortic and intracoronary trans-stenotic pressure signals in a 62-year-old
man. The patient had angiographically intermediate stenosis (68% diam-
eter stenosis) of the mid left anterior descending coronary artery (A and B;
right anterior oblique and left anterior oblique coronary arteries projections,
respectively). The pressure recordings in C were simultaneously obtained
by the guiding catheter (fluid-filled) (solid line) and the pressure wire
(dotted line), while the sensor of the pressure wire was located both
proximal and distal to the lesion. Distal pressure recording was obtained
both at baseline and during adenosine-induced hyperemia (C). When
reached to maximal hyperemic state by administrating incremental dosages
of adenosine, the calculated fractional flow reserve (FFR) was found to be
0.57. The distal pressure waveform in D (lower waveform) was significantly
altered as compared with the baseline proximal signal (upper waveform).
This is especially prominent with regard to the absence of the dicrotic
notch in the distal waveform, indicating attenuation of the high-frequency
components of the pressure waveform across the stenosis and resulting in
a pulse transmission coefficient value of 0.32, which suggest, in accordance
with the FFR value, a functionally significant lesion. Continued on next
page.
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Figure 3. Continued from previous page.
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high-frequency components of the pressure waveform
across the lesion.
Physiologic assessment of coronary lesions by FFR.
Although the angiographic assessment of coronary stenosis
is the gold standard for assessing coronary disease severity, it
has many limitations (17–19), especially when clinical de-
cisions with regard to the need for intervention have to be
taken for angiographically intermediate lesions. In such
cases, documentation of myocardial ischemia related to the
culprit lesion, obtained by functional test, is essential.
Therefore, in light of the need for complementary physio-
logic assessment and with the recent introduction of min-
iature high-fidelity pressure guidewires FFR has emerged as
an important tool for clinical decision-making with regard
to the need for intervention.
Fractional flow reserve is derived from intracoronary
pressure measurements during maximal hyperemia, induced
pharmacologically by vasodilator agents such as adenosine
or papaverine, and reflects the fraction of the maximal blood
flow across the myocardial bed that can still be obtained in
the presence of an epicardial coronary stenosis (20). An FFR
value of 0.75 can reliably discriminate between functionally
significant lesions, associated with inducible ischemia and
nonsignificant lesions (4–6,20–24). Physiologic assessment
of coronary lesion by FFR has the advantage of being a
lesion-specific index of epicardial conductance, which is
almost independent of any hemodynamic changes, induced
by variation in heart rate, blood pressure or myocardial
contractility during the measurement, and is less affected by
microvascular disease as compared with coronary flow re-
serve (5,15,25,26).
Clinical and technical limitations of FFR. Distal pressure
depends on flow across the stenosis, which is determined by
both epicardial and microvascular resistance. Therefore,
FFR has some limitations in certain clinical conditions, such
as severe microvascular disease and myocardial infarction
remodeling (27), characterized by the development of
highly resistant scar tissue in the target artery territory. Both
conditions may reduce the maximal achieved epicardial
blood flow and may render the FFR value to be overesti-
mated (5,20,28,29). Another clinical condition where FFR
assessment might have limitations is in left ventricular
hypertrophy, where, as a result of disproportional growth of
the vascular bed to the increased myocardial muscle mass,
the FFR cutoff value to indicate inducible ischemia is
expected to be higher than 0.75 with increasing severity of
hypertrophy (25).
In addition, there might be some technical issues that
could limit the use of FFR in the evaluation of coronary
disease severity. Among them are signal drift during the
pressure measurement and difficulties in assessment of ostial
lesions, where damping of the pressure signal, either at rest
or during maximal hyperemia, by the guiding catheter can
lead to a subsequent underestimation of the functional
significance of the interrogated lesion (28). Moreover,
because maximal hyperemia cannot be reached in 10% to
15% of the patients (28), the reliability of FFR in these cases
may be affected. Thus, a nonhyperemic parameter may serve
as an adjunct parameter for the assessment of the physio-
logic significance of CAD.
Study limitations. In this present study, the study popu-
lation consisted of patients that were referred to coronary
catheterization mainly based on clinical grounds. Most of
those who had clinical presentation of positive ischemia did
not undergo further intracoronary physiologic assessment
and FFR measurement and, therefore, were not included in
the study. This may cause some bias in the patient popula-
tion and may explain the poor correlation between FFR and
PTC and the functional test results.
Another potential limitation is that, although our data
suggest a high correlation between PTC and FFR, it seems
that a larger variance in FFR was observed for extreme PTC
values (0 or 1), whereas there was a relative lack of data
points for intermediate PTC values in the range of 0.4 to
0.8 (Fig. 2). A plausible explanation for these findings is
that the lesion may act as a mechanical high-frequency filter
that is characterized by having a cutoff point of physiologic
severity. Only above this threshold point, the lesion sharply
attenuates the high-frequency components of the pressure
waveform as it crosses the stenosis. Therefore, for most
physiologic nonobstructive stenoses with FFR 0.75, the
lesion transmits all frequency components of the pressure
waveform and apparently does not function as a filter. This
may result in PTC values around 1. On the other hand, for
most physiologic obstructive stenoses with FFR 0.75, the
lesion sharply attenuates all the high-frequency compo-
nents, resulting in PTC values around 0. Therefore, sec-
ondary to this binary behavior of the lesion as a high-
frequency filter, there are relatively few data points in the
PTC range of 0.4 to 0.8, as compared with the two ends of
the spectrum (PTC  0 or 1). This, however, may poten-
tially lower the reliability of the sensitivity and specificity as
well as the correlation with FFR at higher values of PTC,
where it may be particularly relevant for the physiologic
lesion assessment after percutaneous coronary interventions.
The present study demonstrates that this nonhyperemic
parameter correlates with FFR and can be easily applied as
an adjunct index to FFR for the physiologic assessment of
CAD.
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APPENDIX
The algorithm steps are outlined below:
1. The measured pressure signal, P(t), is filtered by using a
low pass filter. The resulted filtered signal, Plow(t),
contains only the first six harmonics of the initial P(t)
signal. The signals P(t) and Plow(t) are shown in Figure
1A by solid and dotted lines, respectively.
2. The difference between measured and filtered pressure
signals is calculated: P(t)  P(t)  Plow(t). The
function P(t) is depicted at the bottom of Figure 1B,
and the measured pressure signal P(t) is depicted above
it.
3. The high-frequency components of the pressure signal
are observed at the points of maximum and minimum
pressure and at the dicrotic notch region. Hence, the
region of interest (ROI) is defined by zero values of the
function P(t) adjacent to the minimum of the function.
The ROI is depicted in Figure 1B by a dotted rectangle.
4. The standard deviation (E) of the function P(t) is
calculated within the ROI, where E  stdROI[P(t)].
This standard deviation represents the difference in
filtered versus unfiltered signals within the ROI. The
function E is calculated at proximal and distal locations
across the lesion, and the PTC  Edistal/Eproximal.
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